* Transmedics Group Inc TMDX.OQ reported quarterly
adjusted
earnings of 35 cents per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -8 cents. The mean expectation of
seven analysts for the quarter was for a loss of 5 cents per
share. Wall Street expected results to range from -33 cents
to 11 cents per share.
* Revenue rose 133.1% to $96.85 million from a year ago;
analysts
expected $83.78 million.
* Transmedics Group Inc's reported EPS for the quarter was
35
cents.
* The company reported quarterly net income of $12.2
million.
* Transmedics Group Inc shares had risen by 31.5% this
quarter and
gained 23.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 77.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Transmedics Group
Inc is $100.00
This summary was machine generated from LSEG data April 30 at
11:23 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.05 0.35 Beat
Dec. 31 2023 -0.03 0.12 Beat
Sep. 30 2023 -0.16 -0.78 Missed
Jun. 30 2023 -0.13 -0.03 Beat